DOI:
10.1055/s-00024358
European Journal of Pediatric Surgery Reports
LinksClose Window
References
Bielack SS, Cox MC, Nathrath M. et al.
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Ann Oncol 2019;
30 (Suppl_8, Suppl_8) i31, i35
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.